Galmed Pharmaceuticals (GLMD) Current Assets (2013 - 2025)

Galmed Pharmaceuticals' Current Assets history runs 13 years deep, the most recent figure standing at $18.6 million for Q4 2025.

• In Q4 2025, Current Assets rose 15.52% year-over-year to $18.6 million; the TTM figure through Dec 2025 stood at $18.6 million (up 15.52% YoY), while the FY2025 annual figure was $18.6 million, up 15.52% from the prior year.
• Current Assets was $18.6 million for Q4 2025 at Galmed Pharmaceuticals, down from $19.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $59.7 million in Q1 2021 to a low of $5000.0 in Q1 2023.
• Historically, Current Assets has averaged $22.4 million across 5 years, with a median of $18.2 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Current Assets slumped 99.98% in 2023, then surged 223540.0% in 2024.
• A 5-year view of Current Assets shows it stood at $36.1 million in 2021, then plunged by 59.16% to $14.7 million in 2022, then dropped by 10.09% to $13.2 million in 2023, then grew by 21.79% to $16.1 million in 2024, then advanced by 15.52% to $18.6 million in 2025.
• The last three Current Assets figures came in at $18.6 million (Q4 2025), $19.7 million (Q3 2025), and $21.1 million (Q2 2025), per Business Quant data.